Chair

SIG announces changes in the Board of Directors

Retrieved on: 
Wednesday, April 10, 2024
Annual, Sulzer (manufacturer), Chair, Nomination, SIG, SIX Swiss Exchange, Semen Indonesia Group, Annual general meeting

At the Annual General Meeting of SIG Group AG (“SIG” or “the Group”), to be held on 23 April 2024, all existing members of the Board of Directors will stand for re-election for a one-year term of office.

Key Points: 
  • At the Annual General Meeting of SIG Group AG (“SIG” or “the Group”), to be held on 23 April 2024, all existing members of the Board of Directors will stand for re-election for a one-year term of office.
  • The Board of Directors also proposes the election of Thomas Dittrich as a new member of the Board of Directors for a one-year term.
  • Prior to this, he held various high-level management positions including those of Chief Financial Officer and executive member of the Board of Directors of Shire plc.
  • Andreas Umbach is proposed for re-election as the Chair of the Board of Directors for a one-year term.

Genel Energy PLC: Directorate change

Retrieved on: 
Wednesday, April 10, 2024
Chair, Committee, AGM, Senior, Pleasure, Retirement, UK Corporate Governance Code

Genel Energy plc ('Genel' or 'the Company') announces that Sir Michael Fallon has indicated his intention to retire from the Board of Genel at the AGM in May 2024.

Key Points: 
  • Genel Energy plc ('Genel' or 'the Company') announces that Sir Michael Fallon has indicated his intention to retire from the Board of Genel at the AGM in May 2024.
  • Sir Michael Fallon has served more than four years at Genel as Non-Executive Director, Deputy Chair, Senior Independent Director, Chair of the International Relations Committee, and a member of the Remuneration Committee and the Nomination Committee.
  • The Board intends to appoint a new Independent Non-Executive Director as soon as practically possible.
  • On behalf of the Board, we wish him all the best with his other commitments.”
    For further information please contact:

NCD announces new Chair Claudia L. Gordon

Retrieved on: 
Tuesday, April 9, 2024
Sprint Corporation, Connection, Chair, Congress, Culture, Associate, White, Howard University, National Council, Office, Policy, National Black Deaf Advocates, Mentorship, House, Council, Deafness, AT&T, National Association, Public engagement, NCD, T-Mobile US, Senate

WASHINGTON, April 09, 2024 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD) – an independent, nonpartisan federal agency that advises the President, Congress, and other federal agencies on disability policy – announces Claudia L. Gordon, Esq., of Washington, D.C., as its new Chair.

Key Points: 
  • WASHINGTON, April 09, 2024 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD) – an independent, nonpartisan federal agency that advises the President, Congress, and other federal agencies on disability policy – announces Claudia L. Gordon, Esq., of Washington, D.C., as its new Chair.
  • President Joseph R. Biden, Jr. designated Gordon as Council Chair, as announced by the White House on April 5.
  • During her time at NCD, Gordon was designated by Gallegos as Vice Chair and served on NCD’s Executive Committee.
  • “I am honored to have the opportunity to serve the country in this capacity as Chair and look forward to continuing our journey of increasing accessibility and inclusion in all walks of life,” said NCD Chair Claudia Gordon.

MEF Pioneers Industry Leading Enterprise Business and Operational LSO API Portfolio for Network Services

Retrieved on: 
Tuesday, April 9, 2024
Automation, SD-WAN, Growth, ELC, Verizon Business, Internet of things, LSO, AI, Carrier Ethernet, Network as a service, Ecosystem, API, GNE, Zero trust security model, Chair, MEF, Fine chemical

LOS ANGELES, April 09, 2024 (GLOBE NEWSWIRE) -- MEF , a global industry association of network, cloud, security, and technology providers accelerating enterprise digital transformation, today announced availability of its MEF enterprise business and operational Lifecycle Service Orchestration (LSO) API portfolio .

Key Points: 
  • LOS ANGELES, April 09, 2024 (GLOBE NEWSWIRE) -- MEF , a global industry association of network, cloud, security, and technology providers accelerating enterprise digital transformation, today announced availability of its MEF enterprise business and operational Lifecycle Service Orchestration (LSO) API portfolio .
  • "MEF’s enterprise business and operational LSO API portfolio is a game-changer for enterprises undergoing digital transformation," said Debika Bhattacharya, Chair, MEF Board of Directors, and Chief Technology Solutions Officer, Verizon Business.
  • The MEF enterprise business and operational LSO API portfolio enables service providers to use the same APIs that automate business and operational functions between service providers to automate similar functions between service providers and enterprises for subscriber services, thereby streamlining enterprise digital transformation.
  • MEF enterprise business and operational LSO APIs are available for Carrier Ethernet (E-Line, E-LAN and E-Tree) and traditional IP Broadband and Direct Internet Access network services.

The Canadian Centre on Substance Use and Addiction Welcomes Scott Elliott to its Board of Directors

Retrieved on: 
Monday, April 8, 2024
Addiction, Mental health, Chair, Substance, HIV, Knowledge, The Honourable, Research, Health Canada, Parliament, DSM-IV codes, CCSA

“Scott is known for his efforts in tackling substance use health issues and finding unique, powerful solutions.

Key Points: 
  • “Scott is known for his efforts in tackling substance use health issues and finding unique, powerful solutions.
  • Mr. Elliott is the Chief Executive Officer of the Dr. Peter Centre in Vancouver, B.C.
  • The Centre provides clinical, social and psychological support to marginalized community members living with HIV, complex medical conditions, mental illness, and substance use and addictions.
  • “People in Canada will benefit from Scott’s understanding of community building and the diverse experiences across substance use health.”
    Mr. Elliott joins 12 other directors to complete CCSA’s volunteer Board of Directors.

Theratechnologies Appoints Elina Tea to its Board of Directors

Retrieved on: 
Friday, April 5, 2024
Corporation, SNC-Lavalin, McGill University, Chair, Desjardins Group, Office of the President, Commerce, TSX, GLS, M&A, Corporate development, RBC Capital Markets, Management

Tea will be Investissement Québec’s designee pursuant to its investor rights agreement with the Company.

Key Points: 
  • Tea will be Investissement Québec’s designee pursuant to its investor rights agreement with the Company.
  • “Elina Tea’s extensive experience in finance, corporate strategy, and investor relations makes her a valuable addition to our Board of Directors,” said Dawn Svoronos, Chair of the Board of Directors at Theratechnologies.
  • She brings a welcomed perspective to Theratechnologies as the Company focuses on its commercial business and the search for new products and partners.”
    “It’s an honor to join the distinguished Board of Directors of Theratechnologies and I look forward to contributing to the Company’s path to success and value creation,” said Elina Tea.
  • With the appointment of Elina Tea, the Company’s Audit Committee will now comprise four independent members including the recently appointed Jordan Zwick, Gerald Lacoste, and Frank Holler as Chair.

Mayfair Gold Sets the Record Straight and Corrects Muddy Waters’ Misleading and Inaccurate Statements

Retrieved on: 
Thursday, April 4, 2024
Chair, Muddy Waters, Letter, Trust, Research, MFG, Compensated emancipation, Hand, Legislation, Management

The Company also wishes to set the record straight and correct misleading and inaccurate statements made by Muddy Waters in the Letter.

Key Points: 
  • The Company also wishes to set the record straight and correct misleading and inaccurate statements made by Muddy Waters in the Letter.
  • Contrary to Muddy Waters’ assertion that it hoped to resolve issues with the Company quickly, it has consistently refused to engage in a constructive dialogue with Mayfair.
  • The Letter also makes a number of unsubstantiated statements about compensation for directors and management which require clarification and context.
  • No shareholder other than Muddy Waters has expressed any concerns to the Board or management regarding the Company’s compensation practices.

Resolutions of Nokia Corporation’s Annual General Meeting and Board of Directors’ Assembly Meeting

Retrieved on: 
Wednesday, April 3, 2024
Annual, EUR, Chair, Committee, Travel, Chairperson, AGM, KHT, Policy, Audit committee, MacNamara, Treasury, KRT, Corporate governance, Industrial design

Composition of the Board of Directors, Board committees

Key Points: 
  • Composition of the Board of Directors, Board committees
    The AGM resolved to elect ten members to the Board.
  • In an assembly meeting that took place after the AGM, the Board elected Sari Baldauf as Chair and Søren Skou as Vice Chair of the Board.
  • The meeting fees, travel expenses and other expenses directly related to Board and Board Committee work will be paid in cash.
  • The authorization is effective until 2 October 2025 and it terminated the corresponding authorization granted by the Annual General Meeting on 4 April 2023.

Spectral Medical Chair to Retire From the Board of Directors

Retrieved on: 
Tuesday, April 2, 2024
Sepsis, Chair, Mortality, Septic shock, PMX, TSX, Retirement, Management

Mr. Bihl has been a Director of the Company for 16 years and was appointed to the role of Chairman in 2010.

Key Points: 
  • Mr. Bihl has been a Director of the Company for 16 years and was appointed to the role of Chairman in 2010.
  • Mr. Bihl will step down as Chair, effective April 2, 2024, but will remain a director until his retirement from the board in June.
  • “It has been my pleasure to serve Spectral for 16 years, including the last 14 years as Chairman.
  • I have been fortunate to work with Tony for the last three years and I wish him well for the future,” said Chris Seto, CEO of Spectral Medical.

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Friday, March 29, 2024
Retina, Chair, Three Months, Biologics license application, Secretome, Disease, Infection, Incidence, Paratriathlon, Inflammation, Patient, Sale, Limbal stem cell, Research, CIRM, Acquisition, Commercial, Eye, Safety, Retinitis pigmentosa, Food, FDA, BLA, Stargardt disease, Physician, Contingency, Protease, Cryptocurrency

ARLINGTON, Mass., March 29, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.

Key Points: 
  • “In 2023, we focused on clinical execution, advancing our Phase 2b CHASE trial of KPI-012 for the treatment of PCED.
  • In December 2023 and March 2024, KALA announced private placement financings with an institutional investor, priced at-the-market under Nasdaq rules.
  • Cash Position: As of December 31, 2023, KALA had cash and cash equivalents of $50.9 million, compared to $56.1 million as of September 30, 2023.
  • Operating Loss: For the quarter ended December 31, 2023, loss from operations was $9.6 million, compared to $10.3 million for the same period in 2022.